What the new rule on medication-assisted treatment via telehealth means for providers - Healthcare IT News
New rule expands telehealth prescribing of buprenorphine for medication-assisted treatment (MAT) without requiring an in-person visit, but imposes new patient monitoring and recordkeeping requirements.
Aforeworn detected this change in the Telehealth Cross-State Licensing space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Telehealth platforms, virtual specialty clinics, behavioral-health providers, e-prescribers should confirm how it applies to their specific situation before acting. There is a time constraint attached: Effective 60 days from publication; compliance expected by [date].. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Telehealth Cross-State Licensing continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Providers can now prescribe buprenorphine via telehealth for MAT without an initial in-person exam, but must conduct periodic follow-up visits (at least monthly for first 6 months) and maintain detailed records of patient assessments and outcomes.
Who it affects
Telehealth platforms, virtual specialty clinics, behavioral-health providers, e-prescribers
What you must do
Update clinical protocols to include mandatory monthly follow-up visits and enhanced documentation for MAT patients initiated via telehealth.
Deadline
Effective 60 days from publication; compliance expected by [date].
Never miss a change like this again
Aforeworn watches Telehealth Cross-State Licensing around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Telehealth Cross-State Licensing
- DEA Proposes a Special Registry for Telehealth Providers of Controlled Substances - MedPage Today
- DEA Releases Long-Awaited Telehealth Special Registration Proposal, but Adoption Is Uncertain - McDermott+
- DEA Extends Telemedicine Flexibilities for Ketamine Prescribing: What Clinics Need to Know in 2026 - JD Supra
- Georgia medical board will limit virtual prescriptions - Atlanta Journal-Constitution
- DEA Proposed Telemedicine Prescribing Rule Could Burden Hospice Physicians and Hospice Operations - Morgan Lewis